StonvexLoading…
StonvexStonvexStonvexCore line items from IRIX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-03 | Annual 2024 2024-12-28 | Annual 2023 2023-12-30 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $52.67M | $48.67M | $51.87M | $56.97M |
Operating Income | $-2.57M | $-8.30M | $-10.01M | $-7.54M |
Net Income | $-4.44M | $-8.91M | $-9.57M | $-7.55M |
EPS (Diluted) | $-0.26 | $-0.54 | $-0.59 | $-0.47 |
Total Assets | $29.15M | $29.14M | $34.44M | $42.29M |
Total Liabilities | $24.23M | $27.04M | $24.91M | $25.06M |
Cash & Equivalents | $6.03M | $2.39M | $7.03M | $13.92M |
Free Cash Flow OCF − CapEx | $-2.26M | $-7.30M | $-6.85M | $-9.80M |
Shares Outstanding | 17.31M | 16.64M | 16.25M | 15.99M |